Ibrahim B. Dagher, Director of Brainstorm Cell Therapeutics BCLI, has filed 0 purchases and 1 sale on the open market. The latest trade was on 02/26.

ID

ID

Ibrahim B. Dagher

Director

Company

Brainstorm Cell Therapeutics BCLI

First filing

24/07/24

Trades

3 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

02/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Brainstorm Cell TherapeuticsBCLI	Open-market sale	24/07/19	24/07/24	63,000 sh	$0.35	$22,050	−100.0%